Company Overview of Reliable Biopharmaceutical Corporation
Reliable Biopharmaceutical Corporation engages in the development and manufacture of active pharmaceutical and high purity ingredients for pharmaceutical, biopharmaceutical, generic pharmaceutical, biotechnology, and cosmetic companies. The company also manufactures cGMP controls for high purity inactive ingredients, including excipients, enzymes, buffers, and surfactants for use in intermediate processing and purification of biologic drugs; and detergents that are used in biopharmaceutical development and manufacturing to disrupt cell membranes (cell lysis) and to solubilize intracellular materials. In addition, it manufactures critical processing aids, cosmeceuticals, and diagnostic compon...
1945 Walton Road
St. Louis, MO 63114
Founded in 1968
Key Executives for Reliable Biopharmaceutical Corporation
Chief Executive Officer, President and Director
Vice President of Finance and Administration
Vice President of Operations
Director of Sales and Marketing
Compensation as of Fiscal Year 2015.
Reliable Biopharmaceutical Corporation Key Developments
Reliable Biopharmaceutical Corporation Expands GMP Detergents Offering for the Biopharmaceutical Market
Aug 18 15
Reliable Biopharmaceutical Corporation has expanded its cGMP detergents offering to include Polysorbate 20 (Tween® 20), Polysorbate 80 (Tween® 80) and TritonTM X100. The addition of these nonionic detergents complement the existing Ionic detergents Sodium Dodecyl Sulfate (SDS) and Lithium Dodecyl Sulfate (LDS), as well as the Chaotropic agent, USP Urea, currently offered by Reliable Biopharmaceutical Corp. Detergents are used in biopharmaceutical development and manufacturing to disrupt cell membranes (cell lysis) and to solubilize intracellular materials. Detergents break the protein protein, proteinlipid or lipidlipid associations. It can be used to denature proteins or other macromolecules and help to prevent unspecific binding when used in immunochemistry and protein crystallization/purification.
Reliable Biopharmaceutical Corporation and Wilshire Technologies Launch Phytochol® for the Cell Culture Market
May 20 14
Reliable Biopharmaceutical Corporation in partnership with Wilshire Technologies has launched Phytochol®, a vegetal-derived, semi-synthetic GMP Cholesterol for the Biopharmaceutical market. The first is enzymatically–derived cholesterol, the implication being that such Cholesterol is the product of an in vivo microbiological synthesis. What is often not said is that the principal raw material for such a process is the residuals left from the processing of animal fats. The second, and the only true animal free method, involves semi-synthetic production from a vegetal precursor in which the company leverages the fact that various readily available plant sources possess the requisite critical A, B, C, and D ring structure of Cholesterol. Utilizing natural extraction and synthetic-chemistry developed by Wilshire Technologies, the company has launched the plant-derived (vegetal), semi-synthetic GMP cholesterol (Phytochol®) that is chemically and physically indistinguishable from the animal-based product.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries